Asia-Pacific Pharmaceutical Contract Manufacturing Market - By Type (Active Pharmaceutical Ingredient manufacturing, Finished Dosage Formulation Development and Manufacturing, Secondary Market), Country, Trends, Forecasts - (2020 - 2025)

Looking to buy the report?

The APAC pharmaceutical contract manufacturing market was worth USD XX.XX billion in 2017 and is projected to reach USD XX.XX billion by 2022, at a CAGR of XX.XX%. Active Pharmaceutical Ingredient (API) holds the highest market share, while final dosage form is estimated to be the top growing segment during the forecasted period. The companies in the upstream industry are undergoing restructuring so as to focus more on R&D. Added to this, stringent regulations on the pharmaceutical industry are compelling the companies to outsource the manufacturing of drugs.

Contract manufacturing involves the outsourcing of manufacturing of the products to third party vendors. Pharmaceutical contract manufacturers are then given the chemical formulation of the drug from the pharmaceutical company and then prepare/manufacture in their location. The contract manufacturing market is growing significantly since the pharmaceutical companies are focusing more on R&D of the drugs instead of manufacturing the formulated drug to stay competitive in the market.

Pharmaceutical companies are going for fewer vendors to take volume advantage and at the same time reduce logistics costs. The growing number of innovative drugs is driving the market, while in-house manufacturing is a chief constraint. The final dosage form manufacturing is a major opportunity in this sector.

The market is segmented on the basis of dosage formulation and country. Based on dosage formulation, the contract manufacturing market can be segmented into solid dosage formulation, liquid dosage formulation, and injectable dosage formulation.

Some of the key players in the market are:

  • Aenova
  • Baxter BioPharma Solutions
  • Catalent
  • Famar
  • Haupt Pharma
  • Jubilant
  • Pfizer CentreSource
  • Recipharm
  • Vetter

What the Report Offers

  • Market definition along with identification of key drivers and restraints for the market.
  • Market analysis with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Our clients include:


Looking to Customize Report?

Please Enter Email ID

Please Enter Message